-transparent.png){kind=logo}
The role of cyclosporine (CSA) alone or in combination with various chemotherapeutics in the development of renal toxicity was evaluated in rats. Administration of 20 mg/kg/day CSA for 4 weeks caused renal functional and structural changes similar to those reported in man. The combined administration of CSA and various chemotherapeutic drugs with a nephrotoxic potential, such as gentamicin (at therapeutic doses), amphothericin B and ketoconazole, which are frequently used in immunosuppressed patients, did not aggravate the CSA induced toxicity in the rat model. Gentamicin at toxic doses, however, increased CSA nephrotoxicity. Thus, the nephrotoxicity induced by CSA has a different pathogenetic mechanism.
B Ryffel, and
A M Müller, and
M J Mihatsch
February 1991,
Clinical biochemistry,
B Ryffel, and
A M Müller, and
M J Mihatsch
January 1986,
Developments in toxicology and environmental science,
B Ryffel, and
A M Müller, and
M J Mihatsch
January 1995,
Experimental nephrology,
B Ryffel, and
A M Müller, and
M J Mihatsch
May 1998,
Renal failure,
B Ryffel, and
A M Müller, and
M J Mihatsch
September 1987,
Transplantation,
B Ryffel, and
A M Müller, and
M J Mihatsch
July 1989,
Transplantation,
B Ryffel, and
A M Müller, and
M J Mihatsch
November 1985,
The International journal of artificial organs,
B Ryffel, and
A M Müller, and
M J Mihatsch
December 1983,
Annals of internal medicine,
B Ryffel, and
A M Müller, and
M J Mihatsch
January 1986,
Toxicologic pathology,
B Ryffel, and
A M Müller, and
M J Mihatsch
January 1988,
International review of experimental pathology,
